CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-25 | Aynechi Tiba Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-25 | Barretto-Ko Percival Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2023-02-16 | O'Donnell Niall Director | Purchase | +630,400 | $3.17 | $2.0M | 1,326,305 |
| 2023-02-16 | O'Donnell Niall Director | Purchase · Common Stock Warrant (Right to Buy) | +472,800 | 472,800 | ||
| 2023-02-16 | Novo Holdings A/S 10% owner | Purchase | +2,208,000 | $3.17 | $7.0M | 6,722,336 |
| 2023-02-16 | Novo Holdings A/S 10% owner | Purchase · Common Stock Warrant (Right to Buy) | +1,656,000 | 1,656,000 | ||
| 2023-01-03 | Gharib Samir M. President & CFO | Option exercise | +37,500 | 71,111 | ||
| 2023-01-03 | Gharib Samir M. President & CFO | Shares withheld for taxes | −15,293 | $1.15 | $18K | 55,818 |
| 2023-01-03 | Gharib Samir M. President & CFO | Option exercise · Restricted Stock Units | −37,500 | 225,000 | ||
| 2022-12-30 | Charlton Ralph William III Chief Medical Officer | Grant or award | +12,864 | $0.93 | $12K | 12,864 |
| 2022-12-30 | Szwarcberg Javier B. Chief Executive Officer | Grant or award | +14,705 | $0.93 | $14K | 14,705 |
| 2022-12-30 | Gharib Samir M. President & CFO | Grant or award | +1 | $0.93 | $1 | 33,611 |
| 2022-12-05 | Charlton Ralph William III Chief Medical Officer | Grant or award · Restricted Stock Units | +127,000 | 127,000 | ||
| 2022-12-05 | Gharib Samir M. President & CFO | Grant or award · Restricted Stock Units | +149,000 | 149,000 | ||
| 2022-12-05 | Szwarcberg Javier B. Chief Executive Officer | Grant or award · Restricted Stock Units | +444,000 | 444,000 | ||
| 2022-06-30 | Gharib Samir M. President & CFO | Option exercise | +37,500 | 41,132 | ||
| 2022-06-30 | Gharib Samir M. President & CFO | Grant or award | +5,446 | $1.48 | $8K | 46,578 |
| 2022-06-30 | Gharib Samir M. President & CFO | Shares withheld for taxes | −12,968 | $1.74 | $23K | 33,610 |
| 2022-06-30 | Gharib Samir M. President & CFO | Option exercise · Restricted Stock Units | −37,500 | 262,500 |
Page 10 of 12 · 231 trades